Interleukin Combinatorial Therapies
Henrico, US · Founded 2017 · Delaware corporation
Founders & leadership
WK
Webster K. CaveneeNamed on SEC filing
TK
Thomas Kerry McCarterNamed on SEC filing
FC
Franklin C. SalisburyNamed on SEC filing
PF
Paul FisherNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 1 round · 2021
▶$2.6MraisedFeb 2022 · 6 investors · Other Health CareRule 506(b)
▶$2.6MraisedFeb 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Webster K. CaveneeExecutive Officer, Director
- Thomas Kerry McCarterExecutive Officer
- Franklin C. SalisburyExecutive Officer
- Paul FisherExecutive Officer, Director
- Offering amount
- $4.4M
- Amount sold
- $2.6M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Interleukin Combinatorial Therapies raised?
- Interleukin Combinatorial Therapies has disclosed $2.6M raised across 1 round.
- Where is Interleukin Combinatorial Therapies headquartered?
- Interleukin Combinatorial Therapies is headquartered in Henrico, US.